<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Heparin for the prevention of intraventricular haemorrhage in preterm infants - Bruschettini, M - 2016 | Cochrane Library</title> <meta content="Heparin for the prevention of intraventricular haemorrhage in preterm infants - Bruschettini, M - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011718.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Heparin for the prevention of intraventricular haemorrhage in preterm infants - Bruschettini, M - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011718.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011718.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Heparin for the prevention of intraventricular haemorrhage in preterm infants" name="citation_title"/> <meta content="Matteo Bruschettini" name="citation_author"/> <meta content="Lund University, Skane University Hospital" name="citation_author_institution"/> <meta content="matteo.bruschettini@med.lu.se" name="citation_author_email"/> <meta content="Olga Romantsik" name="citation_author"/> <meta content="Lund University, Skane University Hospital" name="citation_author_institution"/> <meta content="Simona Zappettini" name="citation_author"/> <meta content="Health Regional Agency of the Liguria Region" name="citation_author_institution"/> <meta content="Rita Banzi" name="citation_author"/> <meta content="IRCCS ‐ Mario Negri Institute for Pharmacological Research" name="citation_author_institution"/> <meta content="Luca Antonio Ramenghi" name="citation_author"/> <meta content="Istituto Giannina Gaslini" name="citation_author_institution"/> <meta content="Maria Grazia Calevo" name="citation_author"/> <meta content="Istituto Giannina Gaslini" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD011718.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/05/05" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011718.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011718.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011718.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cerebral Ventricles; *Infant, Very Low Birth Weight; Anticoagulants [*therapeutic use]; Cerebral Hemorrhage [mortality, *prevention &amp; control]; Heparin [*therapeutic use]; Infant, Premature; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011718.pub2&amp;doi=10.1002/14651858.CD011718.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011718\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011718\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","ms","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011718.pub2",title:"Heparin for the prevention of intraventricular haemorrhage in preterm infants",firstPublishedDate:"May 5, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011718.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011718.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011718.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011718.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011718.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011718.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011718.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011718.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011718.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011718.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>1746 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011718.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0076"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-sec-0070"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/appendices#CD011718-sec-0081"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/table_n/CD011718StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/table_n/CD011718StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Heparin for the prevention of intraventricular haemorrhage in preterm infants</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Matteo Bruschettini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0003">Olga Romantsik</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0004">Simona Zappettini</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0005">Rita Banzi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0006">Luca Antonio Ramenghi</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information#CD011718-cr-0007">Maria Grazia Calevo</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information/en#CD011718-sec-0084">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 05 May 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011718.pub2">https://doi.org/10.1002/14651858.CD011718.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011718-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011718-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011718-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011718-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011718-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011718-abs-0001" lang="en"> <section id="CD011718-sec-0001"> <h3 class="title" id="CD011718-sec-0001">Background</h3> <p>Preterm birth remains the major risk factor for the development of intraventricular haemorrhage, an injury that occurs in 25% of very low birth weight infants. Intraventricular haemorrhage is thought to be venous in origin and intrinsic thromboses in the germinal matrix are likely to play a triggering role. Heparin activates antithrombin and promotes the inactivation of thrombin and other target proteinases. The administration of anticoagulants such as heparin may offset the increased risk of developing intraventricular haemorrhage and may also reduce the risk of developing parenchymal venous infarct, a condition known to complicate intraventricular haemorrhage. </p> </section> <section id="CD011718-sec-0002"> <h3 class="title" id="CD011718-sec-0002">Objectives</h3> <p>To assess whether the prophylactic administration of heparin reduces the incidence of germinal matrix‐intraventricular haemorrhage in very preterm neonates when compared to placebo, no treatment, or other anticoagulants. </p> </section> <section id="CD011718-sec-0003"> <h3 class="title" id="CD011718-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials (<i>The Cochrane Library</i> 2015), MEDLINE (1996 to 22 November 2015), EMBASE (1980 to 22 November 2015) and CINAHL (1982 to 22 November 2015), applying no language restrictions. We searched the abstracts of the major congresses in the field (Perinatal Society of Australia and New Zealand and Pediatric Academic Societies) from 2000 to 2015. </p> </section> <section id="CD011718-sec-0004"> <h3 class="title" id="CD011718-sec-0004">Selection criteria</h3> <p>Randomised controlled trials, quasi‐randomised controlled trials and cluster trials comparing the administration of early, i.e. within the first 24 hours of life, heparin in very preterm infants (gestational age &lt; 32 weeks). </p> </section> <section id="CD011718-sec-0005"> <h3 class="title" id="CD011718-sec-0005">Data collection and analysis</h3> <p>For each of the included trials, two authors independently extracted data (e.g. number of participants, birth weight, gestational age, dose of heparin, mode of administration, and duration of therapy, etc.) and assessed the risk of bias (e.g. adequacy of randomisation, blinding, completeness of follow up). The primary outcomes considered in this review are intraventricular haemorrhage, severe intraventricular haemorrhage and neonatal mortality. </p> </section> <section id="CD011718-sec-0006"> <h3 class="title" id="CD011718-sec-0006">Main results</h3> <p>Two randomised controlled trials enrolling a total of 155 infants met the inclusion criteria of this review. Both trials compared low‐dose heparin to the same solution without heparin in very preterm newborns requiring umbilical catheterisation. No trials were identified that specifically studied the use of heparin in infants at risk of germinal matrix‐intraventricular haemorrhage. </p> <p>We found no differences in the rates of intraventricular haemorrhage (typical RR 0.93, 95% CI 0.61 to 1.41; typical RD −0.03, 95% CI −0.17 to 0.12; 2 studies, 155 infants; I² = 57% for RR and I² = 65% for RD), severe intraventricular haemorrhage (typical RR 1.01, 95% CI 0.46 to 2.23; typical RD 0.00, 95% CI −0.11 to 0.11; 2 studies, 155 infants; I² = 0% for RR and I² = 0% for RD) and neonatal mortality (typical RR 0.69, 95% CI 0.28 to 1.67; typical RD −0.04, 95% CI −0.14 to 0.06; 2 studies, 155 infants; I² = 28% for RR and I² = 50% for RD). We judged the quality of the evidence supporting these findings as very low (rates of intraventricular haemorrhage) and low (severe intraventricular haemorrhage and neonatal mortality) mainly because of limitations in the study designs and the imprecision of estimates. We found very few data on other relevant outcomes, such as bronchopulmonary dysplasia, pulmonary haemorrhage and patent ductus arteriosus; and no study assessing long‐term outcomes (e.g. neurodevelopmental disability). </p> </section> <section id="CD011718-sec-0007"> <h3 class="title" id="CD011718-sec-0007">Authors' conclusions</h3> <p>There is very limited data on the effect of prophylactic administration of heparin on the incidence and severity of IVH in very preterm neonates. Both the identified trials used heparin in the context of maintaining umbilical line patency and not specifically as an agent to prevent germinal matrix‐intraventricular haemorrhage. Given the imprecision of our estimates, the results of this systematic review are consistent with either a benefit or a detrimental effect of heparin and do not provide a definitive answer to the review question. Limited evidence is available on other clinically relevant outcomes. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011718-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011718-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011718-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011718-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011718-abs-0008">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011718-abs-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011718-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011718-abs-0005">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011718-abs-0004" lang="en"> <h3>The use of the anticoagulant heparin to reduce the risk of intraventricular haemorrhage (i.e. bleeding in the brain) in very preterm infants </h3> <p><b>Review question:</b> Does heparin reduce the risk of intraventricular haemorrhage (i.e. bleeding in the brain) and mortality in very preterm infants? </p> <p><b>Background:</b> Heparin is a drug that modulates blood coagulation together with other factors. On the basis of an observational study in very preterm infants, it has been suggested that the administration of drugs that prevent clotting (anticoagulants) such as heparin may reduce the risk of intraventricular haemorrhage and progression of intraventricular haemorrhage, a frequent complication of preterm neonates. This systematic review synthesises the available evidence on the effectiveness of heparin in preventing intraventricular haemorrhage in very preterm neonates. </p> <p><b>Study characteristics:</b> We included two trials for a total of 155 very preterm newborn infants comparing low‐dose heparin with the same solution without heparin. </p> <p><b>Results:</b> The use of heparin does not reduce the risks of bleeding in the brain, mortality or any other relevant outcomes in very preterm neonates when compared to solution without heparin. </p> <p><b>Conclusions</b>: The results of this systematic review are consistent with either a benefit or a detrimental effect of heparin and do not provide a definitive answer to the review question. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011718-sec-0076" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011718-sec-0076"></div> <h3 class="title" id="CD011718-sec-0077">Implications for practice</h3> <section id="CD011718-sec-0077"> <p>There is very limited data on the effect of prophylactic administration of heparin on the incidence and severity of IVH in very preterm neonates. Both the identified trials used heparin in the context of maintaining umbilical line patency and not specifically as an agent to prevent germinal matrix‐intraventricular haemorrhage. Given the imprecision of our estimates, the results of this systematic review are consistent with either a benefit or a detrimental effect of heparin and do not provide a definitive answer to the review question. Limited evidence is available on other clinically relevant outcomes. </p> </section> <h3 class="title" id="CD011718-sec-0078">Implications for research</h3> <section id="CD011718-sec-0078"> <p>Heparin may reduce the risk of developing parenchymal venous infarct, a thrombotic occlusive condition known to complicate grade 4 IVH. Future trials might therefore evaluate both occurrence and progression of existing GM‐IVH. Moreover, efficacy and safety of different doses, formulations, and routes of administration of heparin might deserve to be investigated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011718-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011718-sec-0022"></div> <div class="table" id="CD011718-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Heparin compared to placebo/no treatment for the prevention of intraventricular haemorrhage in preterm infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Heparin compared to no treatment for the prevention of intraventricular haemorrhage in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants at risk of intraventricular haemorrhage<br/> <b>Setting:</b> Neonatal Intensive Care </p> <p><b>Intervention:</b> Heparin<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Heparin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any Intraventricular Haemorrage (IVH)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.61 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>383 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>356 per 1000</b> <br/> (233 to 540) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severe IVH</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.01</b> <br/> (0.46 to 2.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> <br/> (62 to 303) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal mortality (all‐cause)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b> <br/> (0.28 to 1.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b> <br/> (38 to 227) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The assumed risk is the risk of the control arm.</p> <p><sup>1</sup> Limitations in study design: unclear risk of bias for allocation concealment and reporting bias.<br/> <sup>2</sup> Inconsistency: moderate heterogeneity<br/> <sup>3</sup> Imprecision: small number of patients, few events </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011718-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011718-sec-0023"></div> <section id="CD011718-sec-0024"> <h3 class="title" id="CD011718-sec-0024">Description of the condition</h3> <p>Preterm birth remains the largest risk factor for the development of germinal matrix‐intraventricular haemorrhage (GM‐IVH), an injury that occurs in 25% of very low birth weight infants (<a href="./references#CD011718-bbs2-0065" title="Database of Very Low Birth Weight Infants Born in 2012. Burlington, VT: Vermont Oxford Network, 2013. Nightingale Internet Reporting System, accessed April 4, 2014. ">Vermont Oxford Network 2013</a>), often in the first day of life (<a href="./references#CD011718-bbs2-0017" title="DolfinT , SkidmoreMB , FongKW , HoskinsEM , ShennanAT . Incidence, severity, and timing of subependymal and intraventricular hemorrhages in preterm infants born in a perinatal unit as detected by serial real‐time ultrasound. Pediatrics1983;71(4):541‐6. [PUBMED: 6835737] ">Dolfin 1983</a>). The classification of GM‐IVH was originally developed for the interpretation of computerised tomography (CT) scans and thereafter adapted by ultrasonographers and neonatologists (<a href="./references#CD011718-bbs2-0047" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. [PUBMED: 305471] ">Papile 1978</a>). The grading proposed by Papile is widely used, although magnetic resonance imaging (MRI) has been shown to be more sensitive than brain ultrasound or CT scans in detecting small‐sized cerebral haemorrhages (<a href="./references#CD011718-bbs2-0042" title="NandigamRN , ViswanathanA , DelgadoP , SkehanME , SmithEE , RosandJ . MR imaging detection of cerebral microbleeds: effect of susceptibility‐weighted imaging, section thickness, and field strength. American Journal of Neuroradiology2009;30(2):338‐43. [PUBMED: 19001544] ">Nandigam 2009</a>; <a href="./references#CD011718-bbs2-0048" title="ParodiA , MoranaG , SeverinoMS , MalovaM , NataliziaAR , SanniaA , et al. Low‐grade intraventricular hemorrhage: is ultrasound good enough?. Journal of Maternal‐Fetal and Neonatal Medicine2013; Vol. [Epub ahead of print]. [PUBMED: 23968243] ">Parodi 2013</a>). The classification consists of four grades: grade 1 haemorrhage is confined to the subependymal GM; grade 2 is a small haemorrhage within the ventricular lumen; grade 3 is a large haemorrhage that expands the ventricle; and grade 4 is characterised by parenchymal haemorrhagic venous infarction (<a href="./references#CD011718-bbs2-0047" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. [PUBMED: 305471] ">Papile 1978</a>; <a href="./references#CD011718-bbs2-0066" title="VolpeJJ . Neurology of the Newborn. 5th Edition. Philadelphia, PA: Saunders, 2008. ">Volpe 2008</a>). </p> <p>The aetiology of GM‐IVH is multifactorial, not completely elucidated, and involves the intrinsic vulnerability of the germinal matrix (<a href="./references#CD011718-bbs2-0049" title="PerlmanJM , McMenaminJB , VolpeJJ . Fluctuating cerebral blood‐flow velocity in respiratory‐distress syndrome. Relation to the development of intraventricular hemorrhage. New England Journal of Medicine1983;309(4):204‐9. [PUBMED: 6866033] ">Perlman 1983</a>). This haemorrhagic disorder is thought to be venous in origin (<a href="./references#CD011718-bbs2-0066" title="VolpeJJ . Neurology of the Newborn. 5th Edition. Philadelphia, PA: Saunders, 2008. ">Volpe 2008</a>); and venous vessels are known to be more vulnerable to thrombotic phenomena compared to arteries. Moreover, in the absence of significant environmental fluctuations in cerebral blood flow, thromboses in the tiniest vessels of the germinal matrix are likely to play a crucial and triggering role (<a href="./references#CD011718-bbs2-0022" title="Ghazi‐BirryHS , BrownWR , MoodyDM , ChallaVR , BlockSM , ReboussinDM . Human germinal matrix: venous origin of hemorrhage and vascular characteristics. American Journal of Neuroradiology1997;18(2):219‐29. [PUBMED: 9111655] ">Ghazi‐Birry 1997</a>; <a href="./references#CD011718-bbs2-0046" title="PanethN , RudelliR , KazamE , MonteW . The pathology of germinal matrix intraventricular hemorrhage. Brain damage in the preterm infant. Clinics in developmental medicine. 1st Edition. Vol. 131, London, UK: Mac Keith Press, 1994:23–53. ">Paneth 1994</a>; <a href="./references#CD011718-bbs2-0054" title="RamenghiLA , MoscaF , CounsellS , RutherfordMA . Magnetic resonance imaging of the brain in preterm infants. In: Tortori‐DonatiP , RossiA editor(s). Pediatric Neuroradiology. 1st Edition. Heidelberg, Germany: Springer, 2005:199‐234. ">Ramenghi 2005</a>). Sinovenous thrombosis in the deep venous system as a nosological entity is known to determine late appearance of GM‐IVH in premature infants also in the absence of other risk factors (<a href="./references#CD011718-bbs2-0033" title="KersbergenKJ , GroenendaalF , BendersMJ , vanStraatenHL , NiwaT , NievelsteinRA , et al. The spectrum of associated brain lesions in cerebral sinovenous thrombosis: relation to gestational age and outcome. Archives of Disease in Childhood. Fetal and Neonatal Edition2011;96(6):F404‐9. [PUBMED: 21317440] ">Kersbergen 2011</a>; <a href="./references#CD011718-bbs2-0053" title="RamenghiLA , GillBJ , TannerSF , MartinezD , ArthurR , LeveneMI . Cerebral venous thrombosis, intraventricular haemorrhage and white matter lesions in a preterm newborn with factor V (Leiden) mutation. Neuropediatrics2002;33(2):97‐9. [PUBMED: 12075492] ">Ramenghi 2002</a>). A retrospective analysis investigating the association between thrombophilia and increased risk of developing GM‐IVH estimated an absolute risk of IVH (grade 2 to 4) of 80% for the preterm newborns with a point mutation of the factor V gene, as compared to 14% in absence of the mutation (<a href="./references#CD011718-bbs2-0051" title="PetäjäJ , HiltunenL , FellmanV . Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatric Research2001;49(5):643‐6. [PUBMED: 11328946] ">Petäjä 2001</a>). The combined frequency of established thrombophilic abnormalities in infants with GM‐IVH was 32% (<a href="./references#CD011718-bbs2-0051" title="PetäjäJ , HiltunenL , FellmanV . Increased risk of intraventricular hemorrhage in preterm infants with thrombophilia. Pediatric Research2001;49(5):643‐6. [PUBMED: 11328946] ">Petäjä 2001</a>). The presence of genetic prothrombotic factors significantly increases the risk of developing GM‐IVH to a similar degree as other factors such as low Apgar score or the use of inotropic agents (<a href="./references#CD011718-bbs2-0055" title="RamenghiLA , FumagalliM , GroppoM , ConsonniD , GattiL , BertazziPA , et al. Germinal matrix hemorrhage: intraventricular hemorrhage in very‐low‐birth‐weight infants: the independent role of inherited thrombophilia. Stroke2011;42(7):1889‐93. [PUBMED: 21597013] ">Ramenghi 2011</a>). Moreover, a systematic review of observational studies estimated the impact of thrombophilia on risk of cerebral sinovenous thrombosis in neonates and children (<a href="./references#CD011718-bbs2-0032" title="KenetG , LütkhoffLK , AlbisettiM , BernardT , BonduelM , BrandaoL , et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta‐analysis of observational studies. Circulation2010;121(16):1838‐47. ">Kenet 2010</a>). The development of the haemostatic system in neonates is an age‐dependent process and preterm infants have low levels of both pro‐coagulants and anti‐coagulants factors (<a href="./references#CD011718-bbs2-0064" title="TripodiA , RamenghiLA , ChantarangkulV , DeCarliA , ClericiM , GroppoM , et al. Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests. Haematologica2008;93(8):1256‐9. [PUBMED: 18403390] ">Tripodi 2008</a>). </p> </section> <section id="CD011718-sec-0025"> <h3 class="title" id="CD011718-sec-0025">Description of the intervention</h3> <p>Heparin is produced by basophils and mast cells (<a href="./references#CD011718-bbs2-0025" title="GuytonAC , HallJE . Textbook of Medical Physiology. Vol. 11, Philadelphia: Elsevier Saunders, 2006. ">Guyton 2006</a>). It activates antithrombin by an allosteric conformational change mechanism that specifically enhances factor Xa inactivation and, by a ternary complex bridging mechanism, promotes the inactivation of thrombin and other target proteinases (<a href="./references#CD011718-bbs2-0011" title="BjörkI , LindahlU . Mechanism of the anticoagulant action of heparin. Molecular and Cellular Biochemistry1982;48(3):161‐82. [PUBMED: 6757715] ">Björk 1982</a>; <a href="./references#CD011718-bbs2-0015" title="ChuangYJ , SwansonR , RajaSM , OlsonST . Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin‐activated antithrombin. Journal of Biological Chemistry2001;276(18):14961–71. [PUBMED: 11278930] ">Chuang 2001</a>). Thus, the activated antithrombin inactivates proteases involved in blood clotting, such as thrombin and factor Xa. While antifactor Xa activity requires only the pentasaccharide binding site, the activity of heparin against thrombin is size‐dependent (<a href="./references#CD011718-bbs2-0050" title="PetitouM , HeraultJP , BernatA , DriguezPA , DuchaussoyP , LormeauJC , et al. Synthesis of thrombin inhibiting heparin mimetics without side effects. Nature1999;398(6726):417‐22. [PUBMED: 10201371] ">Petitou 1999</a>). For this reason, low‐molecular‐weight heparin (LMWH) was introduced in order to target factor Xa instead of antithrombin. LMWH has an improved therapeutic index, with a reduced risk of osteoporosis and thrombocytopenia in adults (<a href="./references#CD011718-bbs2-0021" title="GarciaDA , BaglinTP , WeitzJI , SamamaMM , American College of Chest Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141(2 Suppl):e24S‐43S. [PUBMED: 22315264] ">Garcia 2012</a>) and children (<a href="./references#CD011718-bbs2-0043" title="NewallF , JohnstonL , IgnjatovicV , MonagleP . Unfractionated heparin therapy in infants and children. Pediatrics2009;123(3):e510‐8. [PUBMED: 19221154] ">Newall 2009</a>), respectively. It may change coagulation profiles (<a href="./references#CD011718-bbs2-0045" title="O'NeillTJ , TierneyLMJr , ProulxRJ . Heparin lock‐induced alterations in the activated partial thromboplastin time. The Journal of the American Medical Association1974;227(11):1297‐8. [PUBMED: 4405979] ">O'Neill 1974</a>); and may cause heparin‐induced thrombocytopenia in users (<a href="./references#CD011718-bbs2-0052" title="PotterC , GillJC , ScottJP , McFarlandJG . Heparin‐induced thrombocytopenia in a child. Journal of Pediatrics1992;121(1):135‐8. [PUBMED: 1625071] ">Potter 1992</a>), including newborns (<a href="./references#CD011718-bbs2-0062" title="SpadoneD , ClarkF , JamesE , LasterJ , HochJ , SilverD . Heparin‐induced thrombocytopenia in the newborn. Journal of Vascular Surgery1992;15(2):306‐11. [PUBMED: 1735891] ">Spadone 1992</a>). Neonatal overdose, which can be fatal (<a href="./references#CD011718-bbs2-0041" title="MonagleP , StuddertDM , NewallF . Infant deaths due to heparin overdose: time for a concerted action on prevention. Journal of Paediatrics and Child Health2012;48(5):380‐1. [PUBMED: 21679338] ">Monagle 2012b</a>), may be reversed with protamine sulphate (<a href="./references#CD011718-bbs2-0069" title="WiernikowskiJT , ChanA , LoG . Reversal of anti‐thrombin activity using protamine sulfate. Experience in a neonate with a 10‐fold overdose of enoxaparin. Thrombosis Research2007;120(2):303‐5. [PUBMED: 17079003] ">Wiernikowski 2007</a>). Other potential side effects of heparin include elevation of aminotransferase levels (<a href="./references#CD011718-bbs2-0013" title="CarlsonMK , GleasonPP , SenS . Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low‐molecular‐weight heparin‐induced hepatotoxicity. Pharmacotherapy2001;21(1):108‐13. [PUBMED: 11191729] ">Carlson 2001</a>) and hypokalaemia (<a href="./references#CD011718-bbs2-0014" title="ChoR , LeclaireM , KempainenR . Heparin‐induced hyperkalemia in a patient diagnosed with thyroid storm. Annals of Pharmacotherapy2013;47(9):1213‐7. [PUBMED: 24259739] ">Cho 2013</a>). </p> <p>Heparin can be administered either as a liquid, intravenously or subcutaneously, or released by specific catheters whose lumens contain the anticoagulant. In addition, it may be added either directly to the infusate or to fluids used to intermittently flush catheters. Heparin should be given frequently or as a continuous infusion because of its short half‐life, i.e. less than one hour for heparin (<a href="./references#CD011718-bbs2-0038" title="McDonaldMM , JacobsonLJ , HayWWJr , HathawayWE . Heparin clearance in the newborn. Pediatric Research1981;15(7):1015‐18. [PUBMED: 7254945] ">McDonald 1981</a>), three to four hours for LMWH (<a href="./references#CD011718-bbs2-0063" title="StreifW , GoebelG , ChanAK , MassicotteMP . Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Archives of Disease in Childhood ‐ Fetal and Neonatal Edition2003;88(5):F365‐70. [PUBMED: 12937038] ">Streif 2003</a>). High doses of heparin have a longer half‐life, as endothelial cell binding becomes saturated, reducing renal clearance (<a href="./references#CD011718-bbs2-0068" title="WeitzDS , WeitzJI . Update on heparin: what do we need to know?. Journal of Thrombosis and Thrombolysis2010;29(2):199–207. [PUBMED: 19882363] ">Weitz 2010</a>). One unit of heparin, known as a 'Howell unit' after the physiologist who nearly a century ago reported on heparin as an anticoagulant (<a href="./references#CD011718-bbs2-0028" title="HowellWH , HoltE . Two new factors in blood coagulation ‐ heparin and pro‐antithrombin. American Journal of Physiology1918;47:328‐41. ">Howell 1918</a>), corresponds to approximately 2 mcg of heparin, which is the amount to keep 1 mL of blood fluid for 24 hours at 0°C. Many concentrations of heparin are available and range from 1 to 20,000 units/mL. Daily flushes of 10 units/mL heparin are used to maintain patency of central catheters in neonates; flushing is required more frequently (e.g. every 6 to 8 hours) for capped polyvinyl chloride catheters and peripheral heparin locks (<a href="./references#CD011718-bbs2-0040" title="MonagleP , ChanAK , GoldenbergNA , IchordRN , JourneycakeJM , Nowak‐GöttlU , et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141(2 Suppl):e737S‐801S. [PUBMED: 22315277] ">Monagle 2012a</a>). The volume of heparin flush is usually 0.5 to 1 mL, similar to the volume of the catheter; the dose of heparin flush used should not approach therapeutic unit/kg dose (<a href="./references#CD011718-bbs2-0040" title="MonagleP , ChanAK , GoldenbergNA , IchordRN , JourneycakeJM , Nowak‐GöttlU , et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141(2 Suppl):e737S‐801S. [PUBMED: 22315277] ">Monagle 2012a</a>). In preterm neonates receiving larger volumes per body weight of total parenteral nutrition (TPN) solutions, a lower dose of 0.5 units/mL of heparin may be preferable in order to avoid approaching therapeutic amounts (<a href="./references#CD011718-bbs2-0040" title="MonagleP , ChanAK , GoldenbergNA , IchordRN , JourneycakeJM , Nowak‐GöttlU , et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141(2 Suppl):e737S‐801S. [PUBMED: 22315277] ">Monagle 2012a</a>). In this population, the same concentration should be used for arterial lines. </p> </section> <section id="CD011718-sec-0026"> <h3 class="title" id="CD011718-sec-0026">How the intervention might work</h3> <p>The exact mechanism or the unique '<i>primum movens</i>' explaining all cases of GM‐IVH are not known although pathogenesis is likely to differ according to severity and timing of this intracranial haemorrhage. GM‐IVH can derive from catastrophic and sudden haemodynamic changes in the venous flow in those very early and severe cases while a sequence of events seems more probable in less severe cases occurring later in more stable babies, after the first few hours of life (<a href="./references#CD011718-bbs2-0056" title="RamenghiLA . Germinal matrix ‐ intraventricular haemorrhage: still a very important brain lesion in premature infants!. The Journal of Maternal‐Fetal &amp; Neonatal Medicine2015;28(Suppl 1):2259‐60. [PUBMED: 26365359] ">Ramenghi 2015</a>). There is histological evidence that among the potential triggers of GM‐IVH, thrombosis in the microvasculature of the germinal matrix plays a significant role (<a href="./references#CD011718-bbs2-0046" title="PanethN , RudelliR , KazamE , MonteW . The pathology of germinal matrix intraventricular hemorrhage. Brain damage in the preterm infant. Clinics in developmental medicine. 1st Edition. Vol. 131, London, UK: Mac Keith Press, 1994:23–53. ">Paneth 1994</a>). Once venous haemorrhage is initiated within the germinal‐matrix there is a further increase in tissue pressure and venous congestion aggravating venous stasis and venous thrombosis (<a href="./references#CD011718-bbs2-0022" title="Ghazi‐BirryHS , BrownWR , MoodyDM , ChallaVR , BlockSM , ReboussinDM . Human germinal matrix: venous origin of hemorrhage and vascular characteristics. American Journal of Neuroradiology1997;18(2):219‐29. [PUBMED: 9111655] ">Ghazi‐Birry 1997</a>). </p> <p>The presence of hypercoagulability in the first hours of life has been shown to increase the risk of developing GM‐IVH (<a href="./references#CD011718-bbs2-0039" title="McDonaldMM , JohnsonML , RumackCM , KoopsBL , GuggenheimMA , BabbC , et al. Role of coagulopathy in newborn intracranial hemorrhage. Pediatrics1984;74(1):26‐31. [PUBMED: 6739216] ">McDonald 1984</a>) and this is consistent with the above mentioned cascade of events. Although we cannot establish the proportion of thrombosis exclusively triggered by inherited thrombophilic disorders the evidence of thrombosis per se within germinal matrix microvasculature remains an important key factor in the pathogenesis of GM‐IVH (<a href="./references#CD011718-bbs2-0022" title="Ghazi‐BirryHS , BrownWR , MoodyDM , ChallaVR , BlockSM , ReboussinDM . Human germinal matrix: venous origin of hemorrhage and vascular characteristics. American Journal of Neuroradiology1997;18(2):219‐29. [PUBMED: 9111655] ">Ghazi‐Birry 1997</a>; <a href="./references#CD011718-bbs2-0046" title="PanethN , RudelliR , KazamE , MonteW . The pathology of germinal matrix intraventricular hemorrhage. Brain damage in the preterm infant. Clinics in developmental medicine. 1st Edition. Vol. 131, London, UK: Mac Keith Press, 1994:23–53. ">Paneth 1994</a>). Therefore, the early administration of anticoagulants such as heparin may offset this risk of GM‐IVH at least in those babies with congenital thrombophilia aggravated by the hypercoagulable state. Moreover, anticoagulants may prove useful in reducing the risk of developing parenchymal venous infarct, a thrombotic occlusive condition known to complicate grade 4 IVH (<a href="./references#CD011718-bbs2-0066" title="VolpeJJ . Neurology of the Newborn. 5th Edition. Philadelphia, PA: Saunders, 2008. ">Volpe 2008</a>). Beneficial effects of heparin might vary in specific populations, e.g. neonates with complex coagulation disorders, sepsis with disseminated intravascular coagulation, transient neonatal protein C deficiency. Low cord blood levels of protein C (&lt; 0.1 unit/mL) may reflect delayed maturation or increased turnover in certain infants and appear to convey an independent risk of thrombosis (<a href="./references#CD011718-bbs2-0037" title="Manco‐JohnsonMJ , AbshireTC , JacobsonLJ , MarlarRA . Severe neonatal protein C deficiency: prevalence and thrombotic risk. Journal of Pediatrics1991;119(5):793‐8. [PUBMED: 1834822] ">Manco‐Johnson 1991</a>). Taken together, the developmental immaturity of the haemostasis system as well as the frequent need for medical interventions in critically ill preterm infants increase the risk for thromboembolism. These newborns might benefit from heparin treatment by avoiding thrombus formation. On the other hand, retrospective studies have reported an association between heparin exposure and increased risk of GM‐IVH (<a href="./references#CD011718-bbs2-0034" title="LeskoSM , MitchellAA , EpsteinMF , LouikC , GiacoiaGP , ShapiroS . Heparin use as a risk factor for intraventricular hemorrhage in low‐birth‐weight infants. New England Journal of Medicine1986;314(18):1156‐60. [PUBMED: 3960090] ">Lesko 1986</a>; <a href="./references#CD011718-bbs2-0036" title="MalloyMH , CutterGR . The association of heparin exposure with intraventricular hemorrhage among very low birth weight infants. Journal of Perinatology1995;15(3):185‐91. [PUBMED: 7666265] ">Malloy 1995</a>), although the true risk could not be determined because of confounding factors inherent in the study design. </p> </section> <section id="CD011718-sec-0027"> <h3 class="title" id="CD011718-sec-0027">Why it is important to do this review</h3> <p>Three Cochrane Reviews have been published regarding the use of heparin specifically in neonates: 1) "Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters" (<a href="./references#CD011718-bbs2-0060" title="ShahPS , ShahVS . Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD002772.pub3] ">Shah 2008</a>); 2) "Heparin for prolonging peripheral intravenous catheter use in neonates" (<a href="./references#CD011718-bbs2-0059" title="ShahPS , NgE , SinhaAK . Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD002774.pub2] ">Shah 2005</a>); and 3) "Umbilical artery catheters in the newborn: effects of heparin" (<a href="./references#CD011718-bbs2-0007" title="BarringtonKJ . Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000507] ">Barrington 2000a</a>). Barrington also conducted another Cochrane review on umbilical artery catheters from another perspective: the effects of catheter materials, including the presence of heparin in the catheter (<a href="./references#CD011718-bbs2-0008" title="BarringtonKJ . Umbilical artery catheters in the newborn: effects of catheter materials. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000949] ">Barrington 2000b</a>). A fifth Cochrane review assessed the effect of heparin‐bonded central venous catheters on the duration of their patency in children, including neonates (<a href="./references#CD011718-bbs2-0061" title="ShahPS , ShahN . Heparin‐bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD005983.pub3] ">Shah 2014</a>). </p> <p>Each of these reviews included only infants with catheters. The present review has a broader scope and includes the use of heparin for any reason in the first 24 hours of life, including use for prolonging catheter patency. It focuses on very preterm infants, i.e. less than 32 weeks' gestational age, a population where the prevention of GM‐IVH is a major concern. Taking into account the pathophysiological mechanisms of GM‐IVH development, the controversial findings from retrospective studies on GM‐IVH incidence during heparin administration and the increasing use of heparin for catheter patency in preterm newborns, a systematic approach of available evidence is needed. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011718-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011718-sec-0028"></div> <p>To assess whether the prophylactic administration of heparin reduces the incidence of germinal matrix‐intraventricular haemorrhage in very preterm neonates when compared to placebo, no treatment, or other anticoagulants. </p> <p>We planned subgroup analyses according to gestational age, birth weight, requirement for assisted ventilation, presence of GM‐IVH, indication for administration, route of administration, and comparison group, i.e. placebo or no treatment (see <a href="#CD011718-sec-0050">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011718-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011718-sec-0029"></div> <section id="CD011718-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011718-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled clinical trials (RCTs), quasi‐randomised trials and cluster trials. We excluded cross‐over trials. </p> </section> <section id="CD011718-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included newborn infants of less than 32 weeks' gestational age and any birth weight. We also planned to include studies enrolling infants with existing GM‐IVH and to assess the extension of haemorrhage in a subgroup of infants. </p> </section> <section id="CD011718-sec-0033"> <h4 class="title">Types of interventions</h4> <p> <ol id="CD011718-list-0001"> <li> <p>Comparison 1: heparin compared to placebo or no treatment (specific subgroup analyses for each comparison are described in <a href="#CD011718-sec-0050">Subgroup analysis and investigation of heterogeneity</a>); </p> </li> <li> <p>Comparison 2: heparin compared to other anticoagulant treatments, e.g. factor Xa inhibitors and direct thrombin inhibitors. We excluded trials comparing heparin with antithrombin as they are included in a separate Cochrane review (<a href="./references#CD011718-bbs2-0012" title="BruschettiniM , RomantsikO , ZappettiniS , BanziR , RamenghiLA , CalevoMG . Antithrombin for the prevention of intraventricular hemorrhage in very preterm infants. Cochrane Database of Systematic Reviews2015, Issue 4. [DOI: 10.1002/14651858.CD011636] ">Bruschettini 2015</a>). </p> </li> </ol> </p> <p>We included trials testing any dose, mode of administration, and duration of heparin therapy. In addition, we included trials where heparin was administered specifically to prevent GM‐IVH, as well as those where heparin was used to prevent thrombosis (in catheters and other locations). We excluded trials if heparin was: </p> <p> <ul id="CD011718-list-0002"> <li> <p>started beyond the first 24 hours of life (as the aim of the review is to assess the ability of heparin to prevent GM‐IVH); </p> </li> <li> <p>administered to achieve systemic heparinisation, i.e. during extracorporeal membrane oxygenation or for the treatment of thrombosis (regardless of the dosage of heparin); </p> </li> <li> <p>administered through the use of heparin‐bonded catheters.</p> </li> </ul> </p> </section> <section id="CD011718-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD011718-sec-0035"> <h5 class="title">Primary outcomes</h5> <p>1. Germinal matrix‐intraventricular haemorrhage (GM‐IVH):</p> <p> <ul id="CD011718-list-0003"> <li> <p>Any IVH (grade 1 to 4 according to Papile classification) (<a href="./references#CD011718-bbs2-0047" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. [PUBMED: 305471] ">Papile 1978</a>). </p> </li> <li> <p>Severe IVH (grade 3 and 4 according to Papile classification) (<a href="./references#CD011718-bbs2-0047" title="PapileLA , BursteinJ , BursteinR , KofflerH . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. Journal of Pediatrics1978;92(4):529‐34. [PUBMED: 305471] ">Papile 1978</a>). </p> </li> </ul> </p> <p>2. Neonatal all‐cause mortality (first 28 days).</p> </section> <section id="CD011718-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011718-list-0004"> <li> <p>Death during initial hospitalisation (all‐cause mortality).</p> </li> <li> <p>Bronchopulmonary dysplasia (BPD)/Chronic lung disease (CLD): 28 days (<a href="./references#CD011718-bbs2-0044" title="National Institutes of Health. Report of Workshop on Bronchopulmonary Dysplasia. NIH Publication No. 80‐1660. Washington, DC: National Institutes of Health. 1979. ">NIH 1979</a>); 36 weeks postmenstrual age (<a href="./references#CD011718-bbs2-0031" title="JobeAH , BancalariE . Bronchopulmonary Dysplasia. American Journal of Respiratory and Critical Care Medicine2001;163(7):1723‐9. [PUBMED: 11401896] ">Jobe 2001</a>); physiological definition (<a href="./references#CD011718-bbs2-0067" title="WalshMC , YaoQ , GettnerP , HaleE , CollinsM , HensmanA , et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics2004;114(5):1305‐11. [PUBMED: 15520112] ">Walsh 2004</a>). </p> </li> <li> <p>Pneumothorax (on chest x‐ray).</p> </li> <li> <p>Duration of mechanical intermittent positive pressure ventilation (IPPV; days).</p> </li> <li> <p>Duration of respiratory support (IPPV or continuous positive airway pressure, days).</p> </li> <li> <p>Duration of oxygen therapy (days).</p> </li> <li> <p>Duration of hospital stay (days).</p> </li> <li> <p>Retinopathy of prematurity: any and severe (stage 3 or greater; <a href="./references#CD011718-bbs2-0029" title="ICROP . An International Classification of Retinopathy of Prematurity. Pediatrics1984;74(1):127‐33. [PUBMED: 6547526] ">ICROP 1984</a>). </p> </li> <li> <p>Necrotising enterocolitis (any grade and requiring surgery).</p> </li> <li> <p>Need for blood transfusion.</p> </li> <li> <p>Need for medical or surgical treatment for persistent ductus arteriosus (PDA).</p> </li> <li> <p>Pulmonary haemorrhage.</p> </li> <li> <p>Clinically apparent bleeding during treatment in the first week of life.</p> </li> <li> <p>Central catheter (umbilical line or peripherally inserted central catheter) thrombosis (along the length of, or at the tip of, the catheter) as determined by Doppler ultrasonography or contrast venography. </p> </li> <li> <p>Central catheter occlusion, identified by inability to infuse fluids.</p> </li> <li> <p>Peripheral intravenous catheter occlusion.</p> </li> <li> <p>Cerebellar haemorrhage on brain ultrasound in the first month of life.</p> </li> <li> <p>Cystic periventricular leukomalacia on brain ultrasound in the first month of life.</p> </li> <li> <p>Brain MRI abnormalities at term equivalent age (yes/no), defined as: white matter lesions, i.e. cavitations (<a href="./references#CD011718-bbs2-0058" title="RutherfordMA , SupramaniamV , EderiesA , ChewA , BassiL , GroppoM , et al. Magnetic resonance imaging of white matter diseases of prematurity. Neuroradiology2010;52(6):505‐21. [PUBMED: 20422407] ">Rutherford 2010</a>) and punctate lesions (<a href="./references#CD011718-bbs2-0016" title="CornetteLG , TannerSF , RamenghiLA , MiallLS , ChildsAM , ArthurRJ , et al. Magnetic resonance imaging of the infant brain: anatomical characteristics and clinical significance of punctate lesions. Archives of Disease in Childhood. Fetal and Neonatal Edition2002;86(3):F171‐7. [PUBMED: 11978747] ">Cornette 2002</a>); GM‐IVH (<a href="./references#CD011718-bbs2-0048" title="ParodiA , MoranaG , SeverinoMS , MalovaM , NataliziaAR , SanniaA , et al. Low‐grade intraventricular hemorrhage: is ultrasound good enough?. Journal of Maternal‐Fetal and Neonatal Medicine2013; Vol. [Epub ahead of print]. [PUBMED: 23968243] ">Parodi 2013</a>); cerebellar haemorrhage (<a href="./references#CD011718-bbs2-0020" title="FumagalliM , RamenghiLA , RighiniA , GroppoM , BassiL , DeCarliA , et al. Cerebellar haemorrhages and pons development in extremely low birth weight infants. Frontiers in Bioscience2009;1:537‐41. [PUBMED: 19482668] ">Fumagalli 2009</a>; <a href="./references#CD011718-bbs2-0035" title="LimperopoulosC , BassanH , GauvreauK , RobertsonRLJr , SullivanNR , BensonCB , et al. Does cerebellar injury in premature infants contribute to the high prevalence of long‐term cognitive, learning, and behavioral disability in survivors?. Pediatrics2007;120(3):584‐93. [PUBMED: 17766532] ">Limperopoulos 2007</a>). </p> </li> <li> <p>Cerebral haemodynamics impairment, based on cerebral near‐infrared spectroscopy (NIRS).</p> </li> <li> <p>Long‐term neurodevelopmental outcome (yes/no): cerebral palsy on physician assessment, developmental delay, i.e. IQ two standard deviations (SD) below the mean on validated assessment tools e.g. Bayley Mental Developmental Index (<a href="./references#CD011718-bbs2-0009" title="BayleyN . Bayley Scales of Infant Development. 2nd Edition. San Antonio, TX: The Psychological Corporation, 1993. ">Bayley 1993</a>; <a href="./references#CD011718-bbs2-0010" title="BayleyN . Bayley Scales of Infant and Toddler Development. San Antonio, Texas: Harcourt Assessment, 2006. ">Bayley 2006</a>). </p> </li> <li> <p>Major neurodevelopmental disability: cerebral palsy, developmental delay (Bayley Mental Developmental Index (<a href="./references#CD011718-bbs2-0009" title="BayleyN . Bayley Scales of Infant Development. 2nd Edition. San Antonio, TX: The Psychological Corporation, 1993. ">Bayley 1993</a>; <a href="./references#CD011718-bbs2-0010" title="BayleyN . Bayley Scales of Infant and Toddler Development. San Antonio, Texas: Harcourt Assessment, 2006. ">Bayley 2006</a>) or Griffiths Mental Development Scale assessment (<a href="./references#CD011718-bbs2-0023" title="GriffithsR . The abilities of babies: a study in mental measurement. New York, NY: McGraw‐Hill Book Co. Inc, 1954. ">Griffiths 1954</a>) more than two SD below the mean), intellectual impairment (IQ more than two SD below mean), blindness (vision &lt; 6/60 in both eyes), or sensorineural deafness requiring amplification (<a href="./references#CD011718-bbs2-0030" title="JacobsSE , BergM , HuntR , Tarnow‐MordiWO , InderTE , DavisPG . Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database of Systematic Reviews2013, Issue 1. [DOI: 10.1002/14651858.CD003311.pub3] ">Jacobs 2013</a>). We planned to evaluate each of these components as a separate outcome and to extract data on this long‐term outcome from studies that evaluated children after 18 months of chronological age. Data on children aged 18 to 24 months and those aged three to five years were to be assessed separately. </p> </li> </ol> </p> </section> </section> </section> <section id="CD011718-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011718-sec-0038"> <h4 class="title">Electronic searches</h4> <p>We used the criteria and standard methods of Cochrane and the Cochrane Neonatal Review Group (see <a href="http://neonatal.cochrane.org/resources-review-authors" target="_blank">the Cochrane Neonatal Group search strategy for specialized register</a>). </p> <p>We undertook a comprehensive search including:</p> <p> <ul id="CD011718-list-0005"> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) in <i>The Cochrane Library</i>, 2015; </p> </li> <li> <p>MEDLINE (1996 to November 2015);</p> </li> <li> <p>EMBASE (1980 to November 2015);</p> </li> <li> <p>CINAHL (1982 to November 2015);</p> </li> <li> <p>Australian New Zealand Clinical Trials Registry (PSANZ; 2005 to November 2015);</p> </li> <li> <p>abstracts of the Pediatric Academic Societies (PAS; 2000 to November 2015).</p> </li> </ul> </p> <p><a href="./appendices#CD011718-sec-0082">Appendix 1</a> reports the full search strategies for each database. </p> <p>We applied no language restrictions. We searched the reference lists of any cited articles. </p> </section> <section id="CD011718-sec-0039"> <h4 class="title">Searching other resources</h4> <p>We searched clinical trial registries for ongoing or recently completed trials (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a> and <a href="http://controlled-trials.com/" target="_blank">controlled‐trials.com</a>). </p> </section> </section> <section id="CD011718-sec-0040"> <h3 class="title" id="CD011718-sec-0040">Data collection and analysis</h3> <p>We used the standard methods of the Cochrane Neonatal Group. Two review authors (RB, SZ) independently selected the included studies, extracted their data and assessed their risk of bias. At each stage, we resolved disagreements by consensus or by discussion with a third review author (MGC). </p> <section id="CD011718-sec-0041"> <h4 class="title">Selection of studies</h4> <p>Two review authors (RB, SZ) independently screened the titles and abstracts retrieved by the literature search to identify eligible trials that met the inclusion criteria. The review authors then retrieved the full texts of all potentially relevant articles and independently confirmed their eligibility using an eligibility form designed in accordance with the review inclusion criteria. </p> </section> <section id="CD011718-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>Two reviewers (MG, SZ) independently undertook data abstraction using a standardised data extraction form developed ad hoc and integrated with a modified version of the Cochrane Effective Practice and Organisation of Care Group (EPOC) data collection checklist (<a href="./references#CD011718-bbs2-0019" title="EffectivePractice , Organisation of Care(EPOC) . Cochrane EPOC Review Group data collection checklist. EPOC resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2015. Available at: http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/datacollectionchecklist.pdf. ">EPOC 2015</a>). </p> <p>We extracted the following characteristics from each included trial:</p> <p> <ul id="CD011718-list-0006"> <li> <p>Administrative details: author(s); publication status; year the trial was conducted and year of publication; details of other relevant papers cited. </p> </li> <li> <p>Details of the trial: study design; type, duration, and completeness of follow‐up; country and setting of the trial; informed consent and ethics approval. </p> </li> <li> <p>Details of participants: birth weight, gestational age, and number of participants.</p> </li> <li> <p>Details of intervention: type of heparin, dose of heparin, duration of therapy, mode of administration. </p> </li> <li> <p>Details of outcomes, as listed in <a href="#CD011718-sec-0034">Types of outcome measures</a>. </p> </li> </ul> </p> <p>In the case of on‐going trials, we planned to collect data on first author, research question(s), methods, outcome measures, and estimate of the reporting date. </p> <p>We intended to contact the authors of included trials to clarify eligibility and data extraction and to retrieve additional information. One author (MGC) entered the data in the Review Manager 5 software (<a href="./references#CD011718-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and a second one (SZ) checked their accuracy. </p> </section> <section id="CD011718-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two authors (RB, SZ) independently assessed the risk of bias of each of the included trials by using the Cochrane's tool for assessing risk of bias (<a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved disagreements by consensus or, if necessary, by adjudication with a third review author (MGC). We used 'Risk of bias' graphs to illustrate risk across trials. </p> <p>We appraised the following items :</p> <p><b>1. Selection bias (random sequence generation and allocation concealment)</b> </p> <p><i><b>1a. Random sequence generation</b> </i> </p> <p>For each included trial, we categorised the risk of selection bias related to random sequence generation as: </p> <p> <ul id="CD011718-list-0007"> <li> <p>Low risk: the investigators describe a random component in the sequence generation process such as referring to a random number table, using a computer random number generator, coin tossing, shuffling cards or envelopes, throwing dice, drawing of lots, or minimisation; </p> </li> <li> <p>High risk: the investigators describe a non‐random component in the sequence generation process such as sequence generated by odd or even date of birth, sequence generated by some rule based on date or day of admission, sequence generated by some rule based on hospital or clinic record number, allocation by judgment of the clinician, allocation by preference of the participant, allocation based on the results of a laboratory test or a series of tests, or allocation by availability of the intervention; </p> </li> <li> <p>Unclear risk: no or unclear information provided.</p> </li> </ul> </p> <p><b><i>1b. Allocation concealment</i> </b> </p> <p>For each included trial, we categorised the risk of selection bias related to allocation concealment as: </p> <p> <ul id="CD011718-list-0008"> <li> <p>Low risk: participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web‐based, and pharmacy‐controlled randomisation), sequentially numbered drug containers of identical appearance, sequentially numbered sealed opaque envelopes; </p> </li> <li> <p>High risk: participants and investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on open random allocation schedule (e.g. a list of random numbers), unsealed or non‐opaque envelopes, alternation or rotation, date of birth, or case record number; </p> </li> <li> <p>Unclear risk: no or unclear information provided.</p> </li> </ul> </p> <p><b>2. Blinding (performance bias)</b> </p> <p>For each included trial, we categorised the risk of performance bias related to the methods used to blind study personnel from knowledge of which intervention a participant received as: </p> <p> <ul id="CD011718-list-0009"> <li> <p>Low risk: no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding; blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken; </p> </li> <li> <p>High risk: no blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding; blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding; </p> </li> <li> <p>Unclear risk: no or unclear information provided.</p> </li> </ul> </p> <p><b>3. Blinding (detection bias)</b> </p> <p>For each included trial, we categorised the risk of detection bias related to the methods used to blind outcome assessors from knowledge of which intervention a participant received as: </p> <p> <ul id="CD011718-list-0010"> <li> <p>Low risk: no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to be influenced by lack of blinding; blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken; </p> </li> <li> <p>High risk: no blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding; blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding; </p> </li> <li> <p>Unclear risk: no or unclear information provided.</p> </li> </ul> </p> <p><b>4. Incomplete outcome data (attrition bias)</b> </p> <p>For each included trial and for each outcome, we described the risk of attrition bias related to the completeness of data including attrition and exclusions from the analysis as: </p> <p> <ul id="CD011718-list-0011"> <li> <p>Low risk:</p> </li> </ul> <ul class="plain" id="CD011718-list-0012"> <li> <ul id="CD011718-list-0013"> <li> <p>No missing outcome data;</p> </li> <li> <p>Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to introduce bias); </p> </li> <li> <p>Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups; </p> </li> <li> <p>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate; </p> </li> <li> <p>For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size; </p> </li> <li> <p>Missing data have been imputed using appropriate methods.</p> </li> </ul> </li> </ul> <ul id="CD011718-list-0014"> <li> <p>High risk:</p> </li> </ul> <ul class="plain" id="CD011718-list-0015"> <li> <ul id="CD011718-list-0016"> <li> <p>Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups; </p> </li> <li> <p>For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate; </p> </li> <li> <p>For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size; </p> </li> <li> <p>'As‐treated' analysis done with substantial departure of the intervention received from that assigned at randomisation; </p> </li> <li> <p>Potentially inappropriate application of simple imputation.</p> </li> </ul> </li> </ul> <ul id="CD011718-list-0017"> <li> <p>Unclear risk: no or unclear information provided.</p> </li> </ul> </p> <p><b>5. Selective reporting (reporting bias)</b> </p> <p>For each included trial, we described how we investigated the risk of selective outcome reporting bias and what we found. We searched trial registries (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; <a href="http://controlled-trials.com" target="_blank">controlled‐trials.com</a>; and <a href="http://who.int/ictrp" target="_blank">who.int/ictrp</a>) and we intended to contact the study author to have access to the full protocol. </p> <p>We assessed the risk of bias related to the reporting method as:</p> <p> <ul id="CD011718-list-0018"> <li> <p>Low risk: the study protocol is available and all of the study's pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way; or the study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon). </p> </li> <li> <p>High risk: not all of the study’s pre‐specified primary outcomes have been reported; one or more primary outcomes is reported using measurements, analysis methods, or subsets of the data (e.g. subscales) that were not pre‐specified; one or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect); one or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis; or the study report fails to include results for a key outcome that would be expected to have been reported for such a study. </p> </li> <li> <p>Unclear risk: no or unclear information provided (the study protocol was not available).</p> </li> </ul> </p> <p><b>6. Other potential sources of bias (other bias)</b> </p> <p>For each included trial, we described any important concerns we have about other possible sources of bias (for example, whether there was a potential source of bias related to the specific study design used). </p> <p>We assessed the risk of bias related to other problems as:</p> <p> <ul id="CD011718-list-0019"> <li> <p>Low risk: the study appears to be free of other sources of bias;</p> </li> <li> <p>High risk: the trial has at least one important risk of bias (e.g. the trial has a potential source of bias related to the specific study design used or has been claimed to have been fraudulent or had some other problem); </p> </li> <li> <p>Unclear risk: there may be a risk of bias, but there is either insufficient information to assess whether an important risk of bias exists or insufficient rationale or evidence that an identified problem may introduce bias. </p> </li> </ul> </p> </section> <section id="CD011718-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We followed the standard methods of the Cochrane Neonatal Group for data synthesis. We extracted categorical data for each intervention group and calculated relative risks (RRs), relative risk reduction, and absolute risk differences (RDs). For each measure of effect, we provided the corresponding 95% confidence intervals (CIs). If RDs were statistically significant, we would have further calculated numbers needed to treat for an additional beneficial outcome (NNTBs) and numbers needed to treat for an additional harmful outcome (NNTHs). This review does not include outcomes assessed with continuous measures. </p> </section> <section id="CD011718-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>In cluster trials, groups of individuals are randomly allocated to study arms, and outcomes are then measured based on the individual cluster members. Under such circumstances, it is necessary to adjust the results to account for the fact that the randomisation was performed on the clusters rather than the individuals. As many cluster‐randomised trials fail to report appropriate analyses, corrections for clustering are needed before they are included in a meta‐analyses. </p> <p>To calculate adjusted (inflated) CIs that account for the clustering, we planned to follow the approach suggested by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), i.e. to multiply the standard error of the effect estimate (from an analysis ignoring clustering) by the square root of the design effect. The design effect is calculated from the average cluster size and the intra‐cluster correlation coefficient. We planned to derive intra‐cluster correlation coefficient(s) from similar studies and only include trials in meta‐analyses if corrections were possible. </p> </section> <section id="CD011718-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>We recorded drop‐out rate for each trial. A drop‐out rate equal to or greater than the event rate of the control group was considered as significant and additional information was sought by the trial author(s) to facilitate an intention‐to‐treat analysis. When this was not possible, we performed a complete case analysis. </p> </section> <section id="CD011718-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess clinical heterogeneity by comparing the distribution of important participant factors between trials (for example, age) and trial factors (allocation concealment, blinding of outcome assessment, losses to follow‐up, treatment type, co‐interventions). We assessed statistical heterogeneity by examining the I² statistic (<a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>), a quantity that describes the proportion of variation in a point estimate that is due to variability across studies rather than sampling error. We interpreted the I² statistic as described by <a href="./references#CD011718-bbs2-0026" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>: </p> <p> <ul id="CD011718-list-0020"> <li> <p>&lt; 25% – no heterogeneity;</p> </li> <li> <p>25% to 49% – low heterogeneity;</p> </li> <li> <p>50% to 74% – moderate heterogeneity; and</p> </li> <li> <p>≥ 75% – high heterogeneity.</p> </li> </ul> </p> <p>In addition, we planned to do a Chi² test of homogeneity to determine the strength of evidence that heterogeneity was genuine. </p> </section> <section id="CD011718-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>If more than 10 trials had been included, we would have explored publication bias using funnel plots (<a href="./references#CD011718-bbs2-0018" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.)1997;315(7109):629‐34. [PUBMED: 9310563] ">Egger 1997</a>; <a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD011718-sec-0049"> <h4 class="title">Data synthesis</h4> <p>We summarised data using Review Manager 5 (<a href="./references#CD011718-bbs2-0057" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used the standard methods of the Cochrane Neonatal Review Group to synthesise data using RRs, RDs, NNTBs, NNTHs, weighted mean differences (WMDs), and 95% CIs. We preferred a fixed‐effect model to perform meta‐analyses. In case of moderate or high heterogeneity among the trials, we also conducted and reported meta‐analyses using a random‐effects model. </p> <p>Although this was not planned in the review protocol (see <a href="#CD011718-sec-0088">Differences between protocol and review</a>), we summarised the evidence of this review in a 'Summary of findings' table. We used the control arm data to calculate the 'assumed risk' values and select incidence and severity of IVH and all‐cause mortality as critical outcomes. </p> <p>We assessed the overall quality of the evidence for each outcome using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach, as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We considered the following quality domains: study design and limitations, consistency of results, directness (generalisability), precision (sufficient data), and reporting of the results across all studies that measure that particular outcome. The quality starts at high when high quality RCTs provide results for the outcome, and reduces by a level for each of the factors not met. </p> <p> <ul id="CD011718-list-0021"> <li> <p>High quality evidence: there are consistent findings among at least 75% of RCTs with no limitations of the study design, consistent, direct and precise data, and no known or suspected publication biases. Further research is unlikely to change either the estimate or our confidence in the results. </p> </li> <li> <p>Moderate quality evidence: one of the domains is not met. Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low quality evidence: two of the domains are not met. Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low quality evidence: three of the domains are not met. We are very uncertain about the results. </p> </li> <li> <p>No evidence: no RCTs were identified that addressed this outcome.</p> </li> </ul> </p> </section> <section id="CD011718-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses:</p> <p> <ol id="CD011718-list-0022"> <li> <p>Gestational age (with two subgroups: &lt; 28 weeks versus ≥ 28 weeks).</p> </li> <li> <p>Birth weight (with two subgroups: &lt; 1000 grams versus ≥ 1000 grams).</p> </li> <li> <p>Infants requiring assisted ventilation versus infants not requiring assisted ventilation.</p> </li> <li> <p>With or without GM‐IVH (any grade) at trial entry.</p> </li> <li> <p>Trials that used heparin for GM‐IVH prevention (regardless of the dosage) versus other indications, e.g. line patency. </p> </li> <li> <p>Route of administration, e.g. intravenous versus subcutaneous.</p> </li> <li> <p>Heparin compared to placebo versus heparin compared to no treatment.</p> </li> </ol> </p> </section> <section id="CD011718-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>If enough trials had been included, we would have conducted sensitivity analyses to explore the effect of the methodological quality of the trials, checking to ascertain if trials with a high risk of bias overestimate the effect of treatment. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011718-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011718-sec-0052"></div> <section id="CD011718-sec-0053"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD011718-sec-0090" title="">Characteristics of included studies</a> and <a href="./references#CD011718-sec-0091" title="">Characteristics of excluded studies</a>. </p> <section id="CD011718-sec-0054"> <h4 class="title">Results of the search</h4> <p>The literature search run in November 2015 identified 407 references (<a href="#CD011718-fig-0001">Figure 1</a>). After screening, we assessed for eligibility six full‐text articles and included two RCTs (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>; <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>). </p> <div class="figure" id="CD011718-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011718-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>We did not find other relevant trials by searching clinical trials registries (<a href="http://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; <a href="http://controlled-trials.com" target="_blank">controlled‐trials.com</a>; and <a href="http://who.int/ictrp" target="_blank">who.int/ictrp</a>). </p> </section> <section id="CD011718-sec-0055"> <h4 class="title">Included studies</h4> <p>Two trials recruiting 155 infants met the inclusion criteria (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>; <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>). Both trials compared low‐dose heparin (1 unit per mL) with the same solution without heparin in very preterm infants with umbilical catheter. Heparin was administered continuously to the umbilical catheter infusate in <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a> and intermittently in the flush solution in <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>. Study's hypothesis in both trials was that the use of heparin would increase, not prevent, the incidence of GM‐IVH. We identified no trials comparing heparin to other anticoagulants. </p> <p>Details are described in <a href="./references#CD011718-sec-0090" title="">Characteristics of included studies</a>. </p> <p><a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a> was a two‐centre randomised controlled trial enrolling 118 newborns (57 in the heparin group, 61 in the control group) of less than 31 weeks gestation with umbilical catheter, either venous or arterial lines (both venous and arterial lines were studied in this trial). Five infants (two in the heparin group, three in the control group) were randomised but excluded from the analysis as they contravened inclusion criteria (two had chromosomal anomalies, one had a congenital diaphragmatic hernia, one had a congenital cyanotic heart lesion; one was assessed to have been born at greater than 31 weeks' gestation). </p> <p>Within each gestational age block (&lt; 28 and ≥ 28 weeks), randomisation cards were prepared in blocks of 10. Gestational age and birth weight were similar in the two groups, i.e. 27.4 weeks ± 1.8 and 1074 ± 300 grams in the heparin group and 27.1 weeks ± 1.9 and 1065 ± 352 grams in the control group. Less than 40% of the infants were treated with antenatal steroids. All infants received vitamin K intramuscularly. Solutions used to flush all indwelling catheters did not contain heparin. Infants in the intervention group (n = 55) received 1 unit of heparin per mL in their umbilical catheter infusate, whereas control group (n = 58) received the same solution without heparin. All investigators and staff members caring for the infants remained masked, except the pharmacist. The study was conducted from the first through the fifth day of life. The trial ended before the fifth day of life if all umbilical catheters were removed or if a catheter necessitating heparin‐containing infusate was inserted (e.g. a percutaneous intravenous central catheter). All cranial sonograms were performed at one week of life and interpreted by a masked paediatric neuroradiologist. </p> <p><a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a> was a single‐centre randomised controlled trial enrolling 42 infants with birth weight less than 2000 grams and requirement for umbilical artery catheterisation (arterial lines), defined as FiO₂ &gt; 0.4 to maintain PaO₂ &gt; 60 torr. Gestational age and birth weight were similar in the two groups, i.e. 28 weeks ± 3 and 1096 ± 350 grams in the heparin group and 28 weeks ± 3 and 1000 ± 415 grams in the control group. The intervention group of infants (n = 19) received a flush solution with one unit of heparin per mL, while the control group (n = 23) received the same solution without heparin. Solutions were prepared by the hospital pharmacy; staff members caring for the infants remained masked. The flush solutions were used to clear the umbilical artery catheters after routine blood samples (2 to 3 cc of blood to clear the catheter, obtaining the blood specimen, and returning the non‐sample blood to the infant). The catheters were then reconnected to a non‐heparinised intravenous infusion. Cranial sonograms were performed on the first, fourth and seventh postnatal days and reviewed by a masked paediatric radiologist or a neuroradiologist. </p> </section> <section id="CD011718-sec-0056"> <h4 class="title">Excluded studies</h4> <p>We excluded three trials because heparin administration was started beyond 24 hours of life (<a href="./references#CD011718-bbs2-0003" title="BirchP , OgdenS , HewsonM . A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: The Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Archives of Disease in Childhood. Fetal and Neonatal Edition2010;95(4):F252‐7. [PUBMED: 20530110] ">Birch 2010</a>; <a href="./references#CD011718-bbs2-0005" title="KamalaF , BooNY , CheahFC , BirinderK . Randomized controlled trial of heparin for prevention of blockage of peripherally inserted central catheters in neonates. Acta Paediatrica2002;91(12):1350‐6. [PUBMED: 12578294] ">Kamala 2002</a>; <a href="./references#CD011718-bbs2-0006" title="TreasLS , Latinis‐BridgesB . Efficacy of heparin in peripheral venous infusion in neonates. Journal of Obstetric, Gynecologic, and Neonatal Nursing1992;21(3):214‐9. [PUBMED: 1640278] ">Treas 1992</a>); and one trial because the gestational age of infants was greater than 32 weeks (<a href="./references#CD011718-bbs2-0004" title="BrownK , Tay‐UybocoJS , McMillanDD . Heparin is not required for peripheral intravenous locks in neonates. Paediatrics &amp; Child Health1999;4(1):39‐42. [PUBMED: 20212988] ">Brown 1999</a>); (details are reported in <a href="./references#CD011718-sec-0091" title="">Characteristics of excluded studies</a>). </p> </section> </section> <section id="CD011718-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD011718-fig-0002">Figure 2</a> and <a href="#CD011718-fig-0003">Figure 3</a> summarise the risk of bias of the included trial. </p> <div class="figure" id="CD011718-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011718-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011718-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011718-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011718-sec-0058"> <h4 class="title">Allocation</h4> <p><a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a> did not provide sufficient information on how the randomisation sequence was generated and concealed and was then judged at unclear risk of selection bias. </p> <p><a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a> provide information on the allocation sequence generation but not on its concealment. </p> </section> <section id="CD011718-sec-0059"> <h4 class="title">Blinding</h4> <p> The two included trials were designed as blinded. Participants, investigators, and outcome assessors were not aware of the allocated study treatments. </p> </section> <section id="CD011718-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>In <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>, five infants (two in the heparin group, three in the control group) were randomised but excluded from the analysis as they contravened inclusion criteria (two had chromosomal anomalies, one had a congenital diaphragmatic hernia, one had a congenital cyanotic heart lesion; one was assessed to have been born at greater than 31 weeks' gestation). Moreover, five infants died before a sonogram could be obtained and one infant did not have cranial ultra‐sonography performed (two of these infants were in the heparin group, four in the 'no heparin' group). Thus, data on incidence and severity of IVH were available on 107 infants (53 infants in the heparin group, 54 infants in the control group). Overall, 11 out of 118 randomised infants (9.3%) did not complete the study. </p> <p><a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a> reported outcomes for all randomised infants (no drop‐outs). </p> </section> <section id="CD011718-sec-0061"> <h4 class="title">Selective reporting</h4> <p>The included studies were not registered. We were not able to contact the authors of these studies to retrieve the study protocols. Thus, we judged them at unclear risk of bias. </p> </section> <section id="CD011718-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>The trials appeared free of other biases.</p> </section> </section> <section id="CD011718-sec-0063"> <h3 class="title" id="CD011718-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD011718-tbl-0001"><b>Summary of findings for the main comparison</b> Heparin compared to placebo/no treatment for the prevention of intraventricular haemorrhage in preterm infants</a> </p> <section id="CD011718-sec-0064"> <h4 class="title">Heparin versus placebo or no treatment (comparison 1)</h4> <p>Two trials (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>; <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>), which included a total of 155 infants, met eligibility criteria. Both trials compared heparin to the same solution without heparin (see <a href="./full#CD011718-tbl-0001">summary of findings Table for the main comparison</a>). </p> <section id="CD011718-sec-0065"> <h5 class="title">Primary outcomes</h5> <p><b>Any GM‐IVH (grade 1 to 4) (Outcome 1.1):</b> Both studies (n = 155 infants) reported this outcome. Prophylactic administration of heparin did not alter the risk of developing any GM‐IVH (typical RR 0.93, 95% CI 0.61 to 1.41; typical RD −0.03, 95% CI −0.17 to 0.12; 2 studies, 155 infants; I² = 57% for RR and I² = 65% for RD). <i><b>See:</b> </i><a href="./references#CD011718-fig-0007" title="">Analysis 1.1</a><a href="#CD011718-fig-0004">Figure 4</a> </p> <div class="figure" id="CD011718-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.1 Any IVH." data-id="CD011718-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.1 Any IVH.</p> </div> </div> </div> <p><b><i>Severe IVH (grade 3 and 4) (Outcome 1.2):</i> </b> Both trials reported this outcome. Prophylactic administration of heparin did not alter the risk of developing any severe IVH (typical RR 1.01, 95% CI 0.46 to 2.23; typical RD 0.00, 95% CI −0.11 to 0.11; 2 studies, 155 infants; I² = 0% for RR and I² = 0% for RD). <b><i>See:</i> </b><a href="./references#CD011718-fig-0008" title="">Analysis 1.2</a><a href="#CD011718-fig-0005">Figure 5</a> </p> <div class="figure" id="CD011718-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.2 Severe IVH." data-id="CD011718-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.2 Severe IVH.</p> </div> </div> </div> <p><b><i>Neonatal all‐cause mortality (Outcome 1.3):</i> </b> Both trials (n = 155) reported this outcome. Prophylactic administration of heparin did not alter the risk of neonatal mortality (typical RR 0.69, 95% CI 0.28 to 1.67; typical RD −0.04, 95% CI −0.14 to 0.06; 2 studies, 155 infants; I² = 28% for RR and I² = 50% for RD). In <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>, 10 infants in the control group and five in the heparin group died during the study. In <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>, two deaths occurred in the heparin group and one in the control group. <b><i>See:</i> </b><a href="./references#CD011718-fig-0009" title="">Analysis 1.3</a><a href="#CD011718-fig-0006">Figure 6</a> </p> <div class="figure" id="CD011718-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.3 Neonatal all‐cause death." data-id="CD011718-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.3 Neonatal all‐cause death. </p> </div> </div> </div> </section> <section id="CD011718-sec-0066"> <h5 class="title">Secondary outcomes</h5> <p><b><i>Bronchopulmonary dysplasia (Outcome 1.4):</i> </b> One trial reported that bronchopulmonary dysplasia defined as the need for supplemental oxygen at 28 days of age was diagnosed in 21 infants in the heparin group (21/55) versus 18 infants in the control group (18/58) (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>); this difference was not significant (RR 1.23, 95% CI 0.74 to 2.05; RD 0.07, 95% CI −0.10 to 0.25). The test for heterogeneity was not applicable. <b><i>See:</i> </b><a href="./references#CD011718-fig-0010" title="">Analysis 1.4</a> </p> <p><b><i>Pneumothorax (Outcome 1.5):</i> </b> Both trials (n = 155) reported this outcome (typical RR 0.50, 95% CI 0.17 to 1.53; typical RD −0.05, 95% CI −0.14 to 0.03; I² = 57% for RR and I² = 5% for RD) (<a href="./references#CD011718-fig-0011" title="">Analysis 1.5</a>). <b><i>See:</i> </b><a href="./references#CD011718-fig-0011" title="">Analysis 1.5</a> </p> <p><b><i>Patent ductus arteriosus (Outcome 1.6);</i> </b> One trial reported on PDA as diagnosed by physical examination or echocardiogram (RR 0.79, 95% CI 0.54 to 1.16; RD −0.12, 95% CI −0.30 to 0.07) (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>). The test for heterogeneity was not applicable. Need for medical or surgical treatment for PDA was not specified. <b><i>See:</i> </b><a href="./references#CD011718-fig-0012" title="">Analysis 1.6</a> </p> <p><b><i>Pulmonary haemorrhage (Outcome 1.7);</i> </b> One trial reported on this outcome (RR 0.45, 95% CI 0.19 to 1.09; RD −0.13, 95% CI −0.27 to 0.01) (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>). The test for heterogeneity was not applicable. <b><i>See:</i> </b><a href="./references#CD011718-fig-0013" title="">Analysis 1.7</a> </p> <p><b><i>Central catheter occlusion (Outcome 1.8):</i> </b> One trial reported on this outcome (RR 0.40, 95% CI 0.13 to 1.28; RD −0.23, 95% CI −0.49 to 0.02) (<a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>). The test for heterogeneity was not applicable. <b><i>See:</i> </b><a href="./references#CD011718-fig-0014" title="">Analysis 1.8</a> </p> <section id="CD011718-sec-0067"> <h6 class="title">We did not find any data on the following outcomes:</h6> <p>Death during initial hospitalisation (all‐cause mortality); duration of mechanical ventilation; duration of respiratory support; duration of oxygen therapy; duration of hospital stay; retinopathy of prematurity; necrotising enterocolitis; need for blood transfusion; clinically apparent bleeding during treatment; central catheter thrombosis; peripheral intravenous catheter occlusion; cerebellar haemorrhage; cystic periventricular leukomalacia; brain MRI abnormalities at term equivalent age; cerebral haemodynamics impairment; long‐term neurodevelopmental outcome; major neurodevelopmental disability. </p> </section> </section> <section id="CD011718-sec-0068"> <h5 class="title">Subgroup Analysis</h5> <p>We were unable to conduct any of the planned subgroup analyses, as only two trials met the inclusion criteria for this review. </p> </section> </section> <section id="CD011718-sec-0069"> <h4 class="title">Heparin versus other anticoagulant treatments (comparison 2)</h4> <p>We did not find trials comparing heparin to other anticoagulants.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011718-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011718-sec-0070"></div> <section id="CD011718-sec-0071"> <h3 class="title" id="CD011718-sec-0071">Summary of main results</h3> <p>We evaluated the efficacy of the prophylactic administration of heparin in the prevention of GM‐IVH (germinal matrix‐intraventricular haemorrhage) in very preterm infants. Only two trials (<a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>; <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>), for a total of 155 preterm infants, met the inclusion criteria of this review. Heparin was not better than solution or infusate without heparin in terms of incidence or severity of intraventricular haemorrhage and neonatal mortality, the primary outcomes of this review. Heterogeneity was low to moderate for two of our primary outcomes. We could not formally explore the reasons for this heterogeneity due to the small number of included trials, however a possible explanation could be that the two studies used different type of infusion. In terms of secondary outcomes, such as bronchopulmonary dysplasia, pneumothorax, pulmonary haemorrhage and patent ductus arteriosus, we did not find evidence for a benefit. </p> </section> <section id="CD011718-sec-0072"> <h3 class="title" id="CD011718-sec-0072">Overall completeness and applicability of evidence</h3> <p>Both trials compared a low dose of heparin (1 unit per mL) with the same solution without heparin in very preterm infants with umbilical catheter. Importantly, heparin was administered continuously to the umbilical catheter infusate in <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a> and intermittently in the flush solution in <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>. However, even when administered continuously as in <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>, heparin doses received by the infant averaged 4.3 U/kg/h and did not result in clinically significant changes in antithrombin levels. In addition, this review includes trials conducted more than 20 years ago, when the use of antenatal steroid was low (&lt; 40% of the infants enrolled in the more recent trial, i.e. <a href="./references#CD011718-bbs2-0001" title="ChangGY , LuederFL , DiMicheleDM , RadkowskiMA , McWilliamsLJ , JansenRD . Heparin and the risk of intraventricular hemorrhage in premature infants. Journal of Pediatrics1997;131(3):362‐6. [PUBMED: 9329410] ">Chang 1997</a>; not reported in <a href="./references#CD011718-bbs2-0002" title="StecT , MetcalfM , AnwarM , HiattM , HegyiT . The role of heparin in the etiology of intraventricular hemorrhage: a controlled trial. The Journal of Maternal‐Fetal &amp; Neonatal Medicine1993;2(6):283‐7. ">Stec 1993</a>). We did not find trials comparing heparin to other anticoagulants. </p> </section> <section id="CD011718-sec-0073"> <h3 class="title" id="CD011718-sec-0073">Quality of the evidence</h3> <p>According to the GRADE approach, we rated the overall quality of the evidence for clinically relevant outcomes as "low" and "very low" (see <a href="./full#CD011718-tbl-0001">summary of findings Table for the main comparison</a>). We downgraded the overall quality of the evidence for the critical outcomes because of 1) limitations in the study design (i.e. selection bias due to an unclear allocation concealment and reporting bias), and 2) the imprecision of results (a small number of participants) that could be a source of random error risk. The random error is closely related to the imprecision as the results of smaller studies are subject to greater sampling variation and hence are less precise (<a href="./references#CD011718-bbs2-0027" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The estimate of the primary outcome incidence of IVH was also affected by a moderate heterogeneity, thus we further downgraded the overall quality of the evidence supporting this outcome (<a href="./references#CD011718-bbs2-0024" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [PUBMED: 21195583] ">Guyatt 2011</a>). </p> </section> <section id="CD011718-sec-0074"> <h3 class="title" id="CD011718-sec-0074">Potential biases in the review process</h3> <p>As the aim of the present review is to assess the efficacy of heparin to prevent GM‐IVH which mostly occurs in the first three days of life, we excluded trials where the intervention was started beyond the first 24 hours of life, such as <a href="./references#CD011718-bbs2-0003" title="BirchP , OgdenS , HewsonM . A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: The Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Archives of Disease in Childhood. Fetal and Neonatal Edition2010;95(4):F252‐7. [PUBMED: 20530110] ">Birch 2010</a> and <a href="./references#CD011718-bbs2-0004" title="BrownK , Tay‐UybocoJS , McMillanDD . Heparin is not required for peripheral intravenous locks in neonates. Paediatrics &amp; Child Health1999;4(1):39‐42. [PUBMED: 20212988] ">Brown 1999</a>. However, when evaluating the progression of the bleeding, interventions started beyond 24 hours of life may play a relevant role. Importantly, in <a href="./references#CD011718-bbs2-0003" title="BirchP , OgdenS , HewsonM . A randomised, controlled trial of heparin in total parenteral nutrition to prevent sepsis associated with neonatal long lines: The Heparin in Long Line Total Parenteral Nutrition (HILLTOP) trial. Archives of Disease in Childhood. Fetal and Neonatal Edition2010;95(4):F252‐7. [PUBMED: 20530110] ">Birch 2010</a> the continuous infusion of 0.5 IU/mL of heparin started at a mean age of two days of life resulted in significant reduction of the progression of IVH in preterm infants weighing less than 850 g (0/26 IVH progressions in the heparin group versus 4/28 in the control group). </p> </section> <section id="CD011718-sec-0075"> <h3 class="title" id="CD011718-sec-0075">Agreements and disagreements with other studies or reviews</h3> <p>Evidence supports the use of heparin in neonates with peripherally placed percutaneous central venous catheters (<a href="./references#CD011718-bbs2-0060" title="ShahPS , ShahVS . Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD002772.pub3] ">Shah 2008</a>) and umbilical artery catheters (<a href="./references#CD011718-bbs2-0007" title="BarringtonKJ . Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000507] ">Barrington 2000a</a>), but not for peripheral intravenous catheter (<a href="./references#CD011718-bbs2-0059" title="ShahPS , NgE , SinhaAK . Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD002774.pub2] ">Shah 2005</a>). The dose and method of administration of heparin varies widely, with concentrations ranging from 0.1 to 10 U/mL of heparin administered as either intermittent flush solution or as an additive in parenteral nutrition solutions (<a href="./references#CD011718-bbs2-0059" title="ShahPS , NgE , SinhaAK . Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD002774.pub2] ">Shah 2005</a>). Though not corroborated by any high‐quality study, it has been suggested that a low dose of 0.5 units/mL of heparin may be preferable in preterm neonates receiving larger volumes per body weight of total parenteral nutrition (<a href="./references#CD011718-bbs2-0040" title="MonagleP , ChanAK , GoldenbergNA , IchordRN , JourneycakeJM , Nowak‐GöttlU , et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence‐based clinical practice guidelines. Chest2012;141(2 Suppl):e737S‐801S. [PUBMED: 22315277] ">Monagle 2012a</a>). </p> <p>The present review differs from the reviews of Shah and Barrington in the objective and in the inclusion criteria, and consequently in the included trials (<a href="./references#CD011718-bbs2-0007" title="BarringtonKJ . Umbilical artery catheters in the newborn: effects of heparin. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000507] ">Barrington 2000a</a>; <a href="./references#CD011718-bbs2-0008" title="BarringtonKJ . Umbilical artery catheters in the newborn: effects of catheter materials. Cochrane Database of Systematic Reviews2000, Issue 2. [DOI: 10.1002/14651858.CD000949] ">Barrington 2000b</a>; <a href="./references#CD011718-bbs2-0059" title="ShahPS , NgE , SinhaAK . Heparin for prolonging peripheral intravenous catheter use in neonates. Cochrane Database of Systematic Reviews2005, Issue 4. [DOI: 10.1002/14651858.CD002774.pub2] ">Shah 2005</a>; <a href="./references#CD011718-bbs2-0060" title="ShahPS , ShahVS . Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews2008, Issue 2. [DOI: 10.1002/14651858.CD002772.pub3] ">Shah 2008</a>; <a href="./references#CD011718-bbs2-0061" title="ShahPS , ShahN . Heparin‐bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD005983.pub3] ">Shah 2014</a>). We aimed to investigate the effects of early (i.e. within 24 hours of life) administration of heparin for any reason, including promotion of catheter patency. In both included trials heparin was used in infants with umbilical catheter. We will update with new studies if any are published on this topic. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011718-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011718-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011718-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011718-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.1 Any IVH." data-id="CD011718-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.1 Any IVH.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.2 Severe IVH." data-id="CD011718-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.2 Severe IVH.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.3 Neonatal all‐cause death." data-id="CD011718-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Heparin vs no treatment, outcome: 1.3 Neonatal all‐cause death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 1 Any Intraventricular Haemorrhage (IVH)." data-id="CD011718-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 1 Any Intraventricular Haemorrhage (IVH). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 2 Severe IVH." data-id="CD011718-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 2 Severe IVH.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 3 Neonatal all‐cause mortality." data-id="CD011718-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 3 Neonatal all‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 4 Bronchopulmonary dysplasia." data-id="CD011718-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 4 Bronchopulmonary dysplasia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 5 Pneumothorax." data-id="CD011718-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 5 Pneumothorax.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 6 Patent ductus arteriosus." data-id="CD011718-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 6 Patent ductus arteriosus.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 7 Pulmonary haemorrhage." data-id="CD011718-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 7 Pulmonary haemorrhage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011718-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/urn:x-wiley:14651858:media:CD011718:CD011718-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_t/tCD011718-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Heparin vs placebo/no treatment, Outcome 8 Central catheter occlusion." data-id="CD011718-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Heparin vs placebo/no treatment, Outcome 8 Central catheter occlusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/media/CDSR/CD011718/image_n/nCD011718-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011718-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Heparin compared to placebo/no treatment for the prevention of intraventricular haemorrhage in preterm infants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Heparin compared to no treatment for the prevention of intraventricular haemorrhage in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> preterm infants at risk of intraventricular haemorrhage<br/> <b>Setting:</b> Neonatal Intensive Care </p> <p><b>Intervention:</b> Heparin<br/> <b>Comparison:</b> no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> No treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Heparin</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Any Intraventricular Haemorrage (IVH)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.61 to 1.41) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>383 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>356 per 1000</b> <br/> (233 to 540) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Severe IVH</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.01</b> <br/> (0.46 to 2.23) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>137 per 1000</b> <br/> (62 to 303) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal mortality (all‐cause)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.69</b> <br/> (0.28 to 1.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>155<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>136 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>94 per 1000</b> <br/> (38 to 227) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>The assumed risk is the risk of the control arm.</p> <p><sup>1</sup> Limitations in study design: unclear risk of bias for allocation concealment and reporting bias.<br/> <sup>2</sup> Inconsistency: moderate heterogeneity<br/> <sup>3</sup> Imprecision: small number of patients, few events </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Heparin compared to placebo/no treatment for the prevention of intraventricular haemorrhage in preterm infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/full#CD011718-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011718-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Heparin vs placebo/no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Any Intraventricular Haemorrhage (IVH) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.17, 0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Severe IVH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.11, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Neonatal all‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.14, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Bronchopulmonary dysplasia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.10, 0.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pneumothorax <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.14, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Patent ductus arteriosus <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.30, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Pulmonary haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.13 [‐0.27, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Central catheter occlusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐0.49, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Heparin vs placebo/no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011718.pub2/references#CD011718-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011718.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011718-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011718-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011718-note-0004">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011718-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ms#CD011718-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD011718-note-0001">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011718\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011718\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011718\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011718\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011718\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011718.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011718.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011718.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011718.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011718.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718618357"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011718.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718618361"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011718.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd4bd0d34f47a',t:'MTc0MDcxODYxOS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 